NDC Package 0173-0521-00 Serevent Diskus

Salmeterol Xinafoate Powder, Metered Oral; Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

0173-0521-00

Package Description:

1 INHALER in 1 CARTON / 60 POWDER, METERED in 1 INHALER

Product Code:

0173-0521

Proprietary Name:

Serevent Diskus

Non-Proprietary Name:

Salmeterol Xinafoate

Substance Name:

Salmeterol Xinafoate

Usage Information:

Salmeterol is used as a long-term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). It should only be used long-term if your asthma symptoms are not controlled by your other asthma medications (such as inhaled corticosteroids). Salmeterol must not be used alone to treat asthma. (See also Warning section.) It is also used to prevent asthma brought on by exercise (bronchospasm). Salmeterol works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication does not work right away and should not be used for sudden attacks of breathing trouble. Your doctor must prescribe a quick-relief medicine/inhaler (e.g., albuterol) for sudden shortness of breath/asthma attacks while you are on this medication. You should always have a quick-relief inhaler with you. Consult your doctor or pharmacist for more details. This medication should be used in combination with other medications such as long-acting inhaled corticosteroids. However, it should not be used with other long-acting inhaled beta agonists (e.g., formoterol, combination salmeterol/fluticasone) since this may increase your risk for side effects. It is recommended that children and teenagers, who need to use salmeterol to treat their asthma, should use a combination salmeterol/fluticasone product. Check with your child's doctor to see if this product is the right product for your child. In patients with asthma, this medication should not be used when breathing problems can be controlled with inhaled corticosteroids (e.g., flunisolide, fluticasone) and occasional

11-Digit NDC Billing Format:

00173052100

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

1 EA

NDC to RxNorm Crosswalk:

RxCUI: 866048 - salmeterol 50 MCG/INHAL Dry Powder Inhaler, 60 Bisters

RxCUI: 866048 - 60 ACTUAT salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler

RxCUI: 866048 - salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 Actuat

RxCUI: 866049 - Serevent Diskus 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters

RxCUI: 866049 - 60 ACTUAT salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Serevent]

Product Type:

Human Prescription Drug

Labeler Name:

Glaxosmithkline Llc

Dosage Form:

Powder, Metered - An powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity.

Administration Route(s):

Oral - Administration to or by way of the mouth.

Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.

Active Ingredient(s):

SALMETEROL XINAFOATE 50 ug/1

Pharmacologic Class(es):

Adrenergic beta2-Agonists - [MoA] (Mechanism of Action)

beta2-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)

Sample Package:

FDA Application Number:

NDA020692

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

11-25-1997

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

0173 - Glaxosmithkline Llc
- 0173-0521 - Serevent
  - 0173-0521-00 - 1 INHALER in 1 CARTON / 60 POWDER, METERED in 1 INHALER

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0173-0521-00?

The NDC Packaged Code 0173-0521-00 is assigned to a package of 1 inhaler in 1 carton / 60 powder, metered in 1 inhaler of Serevent Diskus, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is powder, metered and is administered via oral; respiratory (inhalation) form.

Is NDC 0173-0521 included in the NDC Directory?

Yes, Serevent Diskus with product code 0173-0521 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on November 25, 1997 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0173-0521-00?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

What is the 11-digit format for NDC 0173-0521-00?

The 11-digit format is 00173052100. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
4-4-2	0173-0521-00	5-4-2	00173-0521-00

Table of Contents